Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience
Cristina Bertoli,1 Tiago Torres,2 Paolo Romita,3 Luca Stingeni,4 Katharina Hansel,4 Luca Mastorino,5 Michela Ortoncelli,5 Michele Panzone,5 Maria João Cruz,6 Luca Bianchi,7 Arianna Zangrilli,7 Maria Letizia Musumeci,8 Giuseppe Micali,8 Carlo Gerbino,8 Oriana Simonetti,9 Edoardo De Simoni,9 Caterina...
Saved in:
| Main Authors: | Bertoli C, Torres T, Romita P, Stingeni L, Hansel K, Mastorino L, Ortoncelli M, Panzone M, Cruz MJ, Bianchi L, Zangrilli A, Musumeci ML, Micali G, Gerbino C, Simonetti O, De Simoni E, Longo C, Mahé E, Di Lernia V |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-06-01
|
| Series: | Psoriasis: Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effectiveness-and-safety-of-adalimumab-biosimilars-in-pediatric-psoria-peer-reviewed-fulltext-article-PTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab
by: Angela Fico, et al.
Published: (2025-05-01) -
Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars
by: Ramya Nair, et al.
Published: (2025-01-01) -
Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01) -
Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study
by: W. H. A. van Poecke, et al.
Published: (2025-07-01) -
Efficacy of switching from originator adalimumab to biosimilar adalimumab-AACF in patients with axial spondyloarthritis: a 12-month observational study
by: Fanny Alcira Reyes Neira, et al.
Published: (2025-02-01)